Amneal gets USFDA approval for Norelgestromin and Ethinyl Estradiol Transdermal System
The company granted 180 days of exclusivity under FDA Competitive Generic Therapy (CGT) approval pathway
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.